Cover Image

Supplementary Figures for manuscript: Weight loss outcomes with tirzepatide in women with and without polycystic ovary syndrome

Fuente: Zenodo

Saved in:

Bibliographic Details
Main Author:	Clift, Ashley Kieran
Format:	Recurso digital
Published:	Zenodo 2026
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effects of kefir consumption on gut microbiota and health outcomes in women with polycystic ovary syndrome
by: Merve Esra Çıtar Dazıroğlu, et al.
Published: (2024)

The role of diet therapy in insulin resistance in women with polycystic ovary syndrome
by: Semenyna H.B., et al.
Published: (2024)

Childbirth experiences in women with polycystic ovary syndrome: A cohort study
by: Anne Engtrø Husby, et al.
Published: (2024)

The impact of androgens on pregnancy and fetal outcomes in patients with polycystic ovary syndrome
by: Ömer Tammo, et al.
Published: (2025)

Gingival inflammation and leukocyte–endothelium cell interactions in women with polycystic ovary syndrome
by: Cecilia Fabiana Márquez‐Arrico, et al.
Published: (2024)

Metformin use in women with polycystic ovary syndrome ( PCOS ): Opportunities, benefits, and clinical challenges
by: Saeede Saadati, et al.
Published: (2025)

A prospective 12‐month structured weight loss intervention in women with severe obesity and polycystic ovary syndrome: Impact of weight loss on eating behaviors
by: Josefin Kataoka, et al.
Published: (2024)

Prevalence of functional hypothalamic amenorrhea in a cohort of women referred because of polycystic ovary syndrome
by: Iris Holzer, et al.
Published: (2024)

Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome
by: Xuelan Li, et al.
Published: (2024)

Homocysteine, vitamin B12, and folate circulating levels in women with and without polycystic ovary syndrome: A systematic review and meta-analysis
by: Ulloque-Badaracco, Juan R., et al.
Published: (2025)

Unraveling mitochondrial dysfunction in polycystic ovary syndrome: Pathophysiological insights.
by: Li, Chia-Jung, et al.
Published: (2025)

Validation of mitochondrial biomarkers and immune dynamics in polycystic ovary syndrome
by: Hui‐Hui Shen, et al.
Published: (2024)

Evaluating serum anti‐Müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome in Pakistani women
by: Anita Dileep, et al.
Published: (2025)

Age and BMI ‐related changes in hormonal profile in women with polycystic ovary syndrome ( PCOS ): Association with infertility
by: Ewa Zabiegło, et al.
Published: (2025)

Dyslipidaemia in women with polycystic ovary syndrome referred to a teaching hospital in Cape Town, South Africa
by: Adrian David Marais, et al.
Published: (2024)

Disclosing α‐lactalbumin impact on the intestinal and vaginal microbiota of women suffering from polycystic ovary syndrome
by: Giulia Alessandri, et al.
Published: (2024)

Bisphenol A and polycystic ovary syndrome in human: A systematic review
by: Lorena Ana Mercedes Lara Urbanetz, et al.
Published: (2024)

Determinants of polycystic ovary syndrome: A matched case–control study
by: Ishwarpreet Kaur, et al.
Published: (2024)

Digital engagement enhances dual GIP / GLP ‐1 receptor agonist and GLP ‐1 receptor agonist efficacy: A retrospective cohort analysis of a digital weight loss service on outcomes and safety
by: Hans Johnson, et al.
Published: (2025)

Impact of insulin sensitization on metabolic and fertility outcomes in women with polycystic ovary syndrome and overweight or obesity—A systematic review, meta‐analysis, and meta‐regression
by: Suhaniya N. S. Samarasinghe, et al.
Published: (2024)

Response: Risk of cancers in women with polycystic ovary syndrome: Cohort study based on health insurance database in South Korea
by: Jin‐Sung Yuk, et al.
Published: (2026)

Combined liraglutide and metformin therapy in overweight or obese women with polycystic ovary syndrome: A systematic review and meta‐analysis
by: Jing Ling, et al.
Published: (2025)

Healthcare and research priorities for women with polycystic ovary syndrome in the UK National Health Service: A modified Delphi method
by: Bassel H. Al Wattar, et al.
Published: (2024)

Association between anti‐Müllerian hormone levels and polycystic ovary syndrome in a general cohort of young women in Japan
by: Natsuki Miyake, et al.
Published: (2024)

A review on the nexus of autophagy genes from the perspective of polycystic ovary syndrome
by: Arifa Khatun, et al.
Published: (2024)

Diagnosing polycystic ovary syndrome at a tertiary level hospital in Latin America
by: Julieth Alexandra Guzmán López, et al.
Published: (2025)

Combined contraceptive pills for androgen excess, not for polycystic ovary syndrome in adolescent girls
by: Francis de Zegher, et al.
Published: (2024)

Predictive model of IVF outcomes for polycystic ovarian morphology and polycystic ovary syndrome in GnRH antagonist protocol using AMH ‐ MoM and ovarian sensitivity index
by: Yoo Ra Ko, et al.
Published: (2024)

X centromeric drive may explain the prevalence of polycystic ovary syndrome and other conditions
by: Tom Moore
Published: (2024)

Associations between kisspeptin hormone level and its genetic polymorphisms with polycystic ovary syndrome
by: Ziyi Zheng, et al.
Published: (2025)

Expression of concern: ‘Metabolic response to selenium supplementation in women with polycystic ovary syndrome: A randomized, double‐blind, placebo‐controlled trial’
Published: (2024)

OP07.06: Understanding dysmenorrhea in women with polycystic ovary morphology: a retrospective study
by: P. Romeo, et al.
Published: (2024)

The impact of androgens on cardiovascular control mechanisms in polycystic ovary syndrome: Recent advances and translational approaches
by: Zoe H. Adams, et al.
Published: (2025)

Leader vs follower in the tango of polycystic ovary syndrome: Insulin resistance vs androgen excess
by: Francis de Zegher, et al.
Published: (2024)

CPEB1 induces autophagy and promotes apoptosis in ovarian granulosa cells of polycystic ovary syndrome
by: Feilan Xuan, et al.
Published: (2024)

Insulin sensitisation for polycystic ovary syndrome: High‐dose monotherapy versus low‐dose combination
by: Francis de Zegher, et al.
Published: (2024)

Letter to the Editor: Diagnosing polycystic ovary syndrome at a tertiary level hospital in Latin America
by: Hinpetch Daungsupawong, et al.
Published: (2025)

Effects of preconceptional vitamin D levels on in vitro fertilization outcomes in infertile patients with polycystic ovary syndrome: A retrospective cohort study
by: Emre Tunçcan, et al.
Published: (2024)

Expression and significance of ependymin‐related protein 1 and neuregulin 4 in the serum of patients with polycystic ovary syndrome
by: Ren Xiaopang, et al.
Published: (2026)

Summary of the 2023 international evidence‐based guideline for the assessment and management of polycystic ovary syndrome: an Australian perspective
by: Helena J Teede, et al.
Published: (2024)